Respiratory tract

COVID-19/Flu A/Flu B Antigen Rapid Test

The COVID-19/Flu A/Flu B Antigen Rapid Test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative  detection and differentiation of nucleocapsid antigen from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Influenza A virus and/or Influenza B virus directly from anterior nasal swab specimens obtained from individuals, who are suspected of respiratory viral  infection consistent with COVID-19 by their healthcare providers, within the first seven days of symptoms onset.